BACKGROUND: In the description of 1 episode schizophrenia patients, female gender is associated with better social function and a higher degree of compliance, while males exhibit more negative symptoms and a higher degree of abuse. The question is raised whether gender specific differences exist which should be taken into consideration in order to provide optimal treatment for the patients. METHODS AND MATERIAL: Data from 269 persons (181 men and 88 women), included in the Danish national schizophrenia project (DNS), were registered at inclusion and year 2, and were analyzed according to gender, social functioning, psychopathology, drug consumption and abuse during the course of 2 years treatment. RESULTS: Women had longer duration of illness before treatment and exhibited more affective symptoms while men were more socially isolated and had more negative symptoms. Alcohol and drug abuse appeared significantly more among men. Women were comparatively more heavily medicated than men. Social function, PANSS negative, drug consumption, affective symptomatology and abuse improved significantly after 2 years follow-up. CONCLUSION: The gender differences demonstrated in the study suggest gender specific treatment interventions in order to provide optimal treatment for both male and female patients.
BACKGROUND: In the description of 1 episode schizophreniapatients, female gender is associated with better social function and a higher degree of compliance, while males exhibit more negative symptoms and a higher degree of abuse. The question is raised whether gender specific differences exist which should be taken into consideration in order to provide optimal treatment for the patients. METHODS AND MATERIAL: Data from 269 persons (181 men and 88 women), included in the Danish national schizophrenia project (DNS), were registered at inclusion and year 2, and were analyzed according to gender, social functioning, psychopathology, drug consumption and abuse during the course of 2 years treatment. RESULTS:Women had longer duration of illness before treatment and exhibited more affective symptoms while men were more socially isolated and had more negative symptoms. Alcohol and drug abuse appeared significantly more among men. Women were comparatively more heavily medicated than men. Social function, PANSS negative, drug consumption, affective symptomatology and abuse improved significantly after 2 years follow-up. CONCLUSION: The gender differences demonstrated in the study suggest gender specific treatment interventions in order to provide optimal treatment for both male and female patients.
Authors: E Simonsen; S Friis; U Haahr; J O Johannessen; T K Larsen; I Melle; S Opjordsmoen; B R Rund; P Vaglum; T McGlashan Journal: Acta Psychiatr Scand Date: 2007-07 Impact factor: 6.392
Authors: Bent Rosenbaum; Kristian Valbak; Susanne Harder; Per Knudsen; Anne Køster; Matilde Lajer; Anne Lindhardt; Gerda Winther; Lone Petersen; Per Jørgensen; Merete Nordentoft; Anne Helms Andreasen Journal: Br J Psychiatry Date: 2005-05 Impact factor: 9.319
Authors: Raimo K R Salokangas; Mika Helminen; Anna-Maija Koivisto; Helena Rantanen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2010-03-20 Impact factor: 4.328
Authors: Andrea Gogos; Luke J Ney; Natasha Seymour; Tamsyn E Van Rheenen; Kim L Felmingham Journal: Br J Pharmacol Date: 2019-03-14 Impact factor: 8.739
Authors: Brooke Carter; Jared Wootten; Suzanne Archie; Amanda L Terry; Kelly K Anderson Journal: Arch Womens Ment Health Date: 2022-06-24 Impact factor: 4.405
Authors: Kim Donoghue; Ian Medley; John Brewin; Cristine Glazebrook; Peter Mason; Roch Cantwell; Peter B Jones; Glynn Harrison; Gillian A Doody Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2009-12-31 Impact factor: 4.328